FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology and gene therapy, and may be used in regenerative medicine, traumatology, transplantology and neurobiology. A method for stimulating the recovered peripheral tissue innervation following an injury comprises administering a therapeutically effective amount of a plasmid vector containing the BDNF-coding nucleotide sequence SEQ ID NO:1, or a plasmid vector containing the human wild-type uPA (NM002658) coding nucleotide sequence, or combinations thereof, or combinations of the plasmid vector containing the BDNF-coding nucleotide sequence SEQ ID NO:1 and a plasmid vector containing a stromal cell factor SDF-1 coding optimised nucleotide sequence SEQ ID NO: 2.
EFFECT: method enables a faster posttraumatic recovery of the peripheral nerve structure and patency due to a local increase of neurotrophic factor production.
3 cl, 9 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
GENETIC ENGINEERING STRUCTURE FOR STIMULATING POST-TRAUMATIC REGENERATION OF PERIPHERAL NERVES | 2019 |
|
RU2719013C1 |
METHOD OF STIMULATING RECOVERY OF DAMAGED TISSUE INNERVATION | 2014 |
|
RU2563541C1 |
METHOD FOR STIMULATING RESTORATION OF TISSUE INNERVATION FOLLOWING INJURIES AND ISCHEMIA BY MEANS OF VECTOR CONSTRUCT | 2013 |
|
RU2538621C2 |
CODON-OPTIMISED SEQUENCES AND PHARMACEUTICAL COMPOSITION FOR RECOVERY OF BLOOD VESSELS | 2014 |
|
RU2557385C1 |
CODON-OPTIMISED RECOMBINANT PLASMID, STIMULATION TECHNIQUE FOR PERIPHERAL NERVE REGENERATION, TREATMENT MODALITY FOR DAMAGED HUMAN NERVE | 2014 |
|
RU2558294C1 |
GENETIC ENGINEERING STRUCTURE FOR ANGIOGENESIS STIMULATION | 2019 |
|
RU2737487C1 |
METHOD FOR INDUCTION OF PERIPHERAL NERVE REGENERATION | 2016 |
|
RU2639175C1 |
METHOD OF ANGIOGENESIS AUGMENTATION IN ISCHEMIC TISSUES AND COMBINATION DRUG FOR METHOD IMPLEMENTATION | 2015 |
|
RU2628706C2 |
MEDICINAL AGENT FOR TREATING HEPATIC FIBROSIS, METHOD FOR PRODUCTION THEREOF AND METHOD OF TREATING HEPATIC FIBROSIS | 2015 |
|
RU2615445C2 |
METHOD OF PRODUCING MAMMAL EMBRYONIC STEM CELLS MODIFIED WITH HUMAN NERVE GROWTH FACTOR GENE | 2011 |
|
RU2458984C1 |
Authors
Dates
2013-07-10—Published
2011-10-25—Filed